AgEagle Aerial Systems Announces Pricing of $10 Million Registered Direct Offering
NEODESHA, Kan., Aug. 05, 2020 (GLOBE NEWSWIRE) — AgEagle Aerial Systems Inc. (NYSE American: UAVS) (the “Company”), an industry leading […]
Spirit Airlines Offers More Go with Five Times the Bonus Miles on Every Flight
MIRAMAR, Fla., Aug. 05, 2020 (GLOBE NEWSWIRE) — Spirit Airlines (NYSE:SAVE) is making it easier for people to earn more […]
The RealReal to Participate in Needham and Raymond James Conferences
SAN FRANCISCO, Aug. 05, 2020 (GLOBE NEWSWIRE) — The RealReal (Nasdaq: REAL)—the world’s largest online marketplace for authenticated, consigned luxury […]
TSX News -
REMINDER/Media Advisory: Bombardier to Report its Second Quarter 2020 Financial Results on August 6, 2020
MONTREAL, Aug. 05, 2020 (GLOBE NEWSWIRE) — Bombardier (TSX: BBD.B) will publish its financial results for the second quarter ended […]
WeedMD Signs Exclusive Licensing Agreement to Produce Mary’s Medicinals Premium Line of Wellness Products
Award-winning products to be manufactured by CX Industries in Canada starting Q4 2020, for sale across all WeedMD’s medical and […]
eXp World Holdings Reports Record Second-quarter Financial Results
Achieves Most Profitable Quarter in Company’s HistoryRevenue Up 33% Year-over-year to $354 MillionBELLINGHAM, Wash., Aug. 05, 2020 (GLOBE NEWSWIRE) — […]
TSX News -
Barrick Lauds Launch of Global Tailings Management Standard
TORONTO, Aug. 05, 2020 (GLOBE NEWSWIRE) — Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) today welcomed the launch of the Global Industry Standard […]
Salarius Pharmaceuticals to Report Second Quarter 2020 Financial Results
HOUSTON, Aug. 05, 2020 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biotechnology company targeting cancers caused by dysregulated […]
Keystone XL Announces Project Labor Agreement with Four U.S. Unions
HOUSTON, Aug. 05, 2020 (GLOBE NEWSWIRE) — Media Advisory – TC Energy Corporation (TSX, NYSE: TRP) (TC Energy) announced today […]
Corbus Pharmaceuticals Completes Enrollment in DETERMINE Phase 3 Study of Lenabasum for Treatment of Dermatomyositis
12-month, double-blind, placebo-controlled, multi-national study enrolled 176 participantsTopline results expected in fourth quarter of 2021Dermatomyositis is a rare, systemic autoimmune […]
